COVID-19 Prevention: Vaccines and Post-Exposure Prophylaxis

September 2026

Questions will come up about 2026-2027 COVID-19 vaccines and the first ORAL med for post-exposure prophylaxis, ensitrelvir (Xocova).

For example, patients may wonder whether COVID-19 vaccines are still needed...or whether this new oral antiviral can take their place.

Emphasize that COVID-19 vaccines remain the best tool to reduce the risk of severe disease, long COVID-19, hospitalization, and death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote